The rescheduling of cannabis from Schedule I to Schedule III by the United States Drug Enforcement Administration (DEA) would be a significant milestone for drug policy reform in the U.S., as it paves the way for the establishment of a federally legal medical cannabis industry.… pic.twitter.com/ElbuIadTcr
TLRY (A legit MJ Company) is skyrocketing due to this news… Many Cannabis sector companies, like ACB as well, are going ballistic after hours. This may change the game.
NOTE for the fools: This doesn’t have to do nothing with ESMERALDA. OKAY? But looking good anyways